Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2026-02-02 @ 2:48 AM
Study NCT ID:
NCT03232567
Status:
COMPLETED
Last Update Posted:
2024-04-30
First Post:
2017-07-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX
Sponsor:
Altimmune, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Influenza | View |
Keywords: